Mutations were made by recombinant DNA techniques in an infectious molecular clone of the human immunodeficiency virus San Francisco isolate 2 (HIVs ) [formerly the prototype isolate of the acquired immunodeficiency syndrome-associated retrovirus (ARV-2)]. The effect of these changes on the replicative and cytopathologic properties of the virus was studied by transfecting modified virus clones into cultured human cells. Mutations in the gag, pol, env, and tat regions precluded virus replication and cytopathology in lymphoid cells. A mutation in orfA dramatically reduced but did not abolish virus replication. Mutant viruses with deletions in the orf-B region were highly cytopathic and replicated to n5-fold higher levels than wild-type virus.
They also produced n5-fold more viral DNA in infected lymphoid cells than did wild-type virus. Thus, the of-B region may function to down-regulate virus replication. This mutational analysis of the HIVSF2 genome is a means of assessing genes regulating viral replication and cytopathology.
Three closely related cytopathic human retroviruses, lymphadenopathy-associated virus (LAV) (1) , human T-lymphotropic virus type III (HTLV-III) (2) , and acquired immunodeficiency syndrome (AIDS)-associated retrovirus (ARV) (3) , have been shown to be etiologically associated with AIDS (4, 5). These isolates have recently been designated human immunodeficiency virus (HIV) (6) . Genomes of these HIV isolates have been molecularly cloned and sequenced (7) (8) (9) (10) . Three large open reading frames (orf) were revealed that encode genes known to be required for virus replication: gag, pol, and env (11) . Two additional open reading frames, designated orf-A and orf-B (12) were also noted. orf-A, containing 203 codons, is located between the 3' end of the HIV pol gene and the start of the env gene; a 23-kDa polypeptide, found in infected cells, is encoded at least in part by this region (13, 14) . Direct amino acid sequencing of p23 indicates that the first of four ATG codons near the 5' end of orf-A is used for initiation (14) . orf-B consists of a stretch of 235 codons overlapping the 3' end of env and extending into the U3 region of the rightward long terminal repeat; a 27-kDa polypeptide derived from this region is expressed in vivo (13, 15, 16) . Two ATG codons in contexts favorable for initiation of translation are found near the 5' end of orf-B.
A feature of the HIV replicative cycle is regulation of viral gene expression by transactivation (17) . The predicted protein of the transactivator (tat) gene is encoded in a spliced viral mRNA composed of three exons, two of which are coding (7, 18) . The first coding exon is located between orf-A and env and specifies 72 amino acids; the second coding exon is composed of sequences in the COOH-terminal domain of env and contributes 14 amino acids to the putative tat gene product (18) . Functional assessments in transient expression assays suggest that the product of the tat gene increases viral gene expression either by acting directly on target sequences in the viral long terminal repeat or by affecting factor(s) that stimulate viral gene expression (19) . The viral anti-repression trans-activator (art) or trans-acting regulator of splicing (trs) gene regulates HIV gene expression by a post-transcriptional mechanism (20, 21) . Viral cytopathology, first described for the effects of poliovirus on cultured cells (22) , is a characteristic feature of infection by many viruses (23) . Several retroviruses, including avian reticuloendotheliosis virus (24, 25) , certain subgroups of avian leukosis viruses (26) , and visna virus (27, 28) Virus Detection. Production of infectious virus by transfected HuT 78 cells was measured by the presence of particle-associated reverse transcriptase activity in the culture supernatant (38) , the detection of viral antigens in the cells by indirect immunofluorescence, and by direct cytopathic effects (3, 33) . Replication of HIV in transfected RD cells was measured by reverse transcriptase activity in cultured supernatant directly or after cocultivation of these cells with permissive HuT 78 cells or human PMCs. In this case, the PMC or HuT cells were left for 3 days and then removed and cultured separately. The culture supernatants were subsequently assayed for reverse transcriptase activity every 3 days after the 3rd day of coculture. Supernatants from the transfected RD cells were also inoculated onto cultures of PMC or HuT 78 cells and then assayed for virus recovery after 1 week.
Construction of Mutant Cloned Proviruses. The p9B-18 is a bacterial plasmid containing the proviral form of HIVSF2 (33, 39) . Infectious cytopathic virus was recovered after transfection of tissue culture cells with p9B-18 (33) . Most of the molecular cloning techniques used have been described (40) . In brief, deletion mutations were generated by treating p9B-18 with either Apa I, Hpa I, Stu I, or Xho I followed by brief exposure to BAL-31 nuclease. All restriction endonucleases and BAL-31 nuclease were from New England Biolabs; these enzymes were used according to the conditions recommended by the manufacturer. The deletion mutation in tat (p9B-5XM) was made by digesting p9B-18 with Xba I and Mlu I, filling in the ends with reverse transcriptase and dNTPs, and ligating the blunt ends. Plasmids were screened by electrophoresis on agarose gels for derivatives of p9B-18 containing small deletions. The exact coordinates of each deletion were determined by DNA sequencing. made at different locations in this HIVSF2 clone ( Table 1 . Effect of Mutations in the gag, pol, and env Regions on HIV Replication and Cytopathology. The DNA transfection experiments with mutant provirus clones involving the major structural genes showed that deletions in gag (p16 region), pol (reverse transcriptase domain), and env (NH2-terminal gpl20 domain) precluded recovery of infectious virus (Table  2) . Thus, as for other retroviruses (41), these genes are required for production of infectious virus particles. In addition, no cytopathic effect was noted in the transfected cells.
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Two coding exons compose the predicted tat gene product (17, 18) . A portion of the coding region near the 5' end of the first exon of tat was removed to produce a deletion mutant A p9B-5XM (Table 1 ). This mutation would be expected to encode a polypeptide specified by the first eight codons of the tat gene and eight additional codons, beyond the Mlu I site in tat, in a different translation frame. No infectious virus was detected after transfection of tissue culture cells with p9B-5XM.
Effect of Mutations in the orf-B Region. Three different deletion mutants in orf-B (p9B-9ZX, p9B-14ZX, and p9B-23ZX) (Table 1) were transfected independently into RD cells or into HuT 78 cells. They gave rise to infectious cytopathic virus (Table 2) , which titered -5-fold greater than that of wild-type virus. This result was reflected by higher reverse transcriptase activity in HuT 78 cells transfected with the orf-B mutant DNA and in HuT 78 cells cocultivated with transfected RD cells ( Table 3 ). The increase in reverse transcriptase activity was not due to a difference in the number of infected HuT 78 cells, since the same percentage of cells (10-20% by indirect immunofluorescence assay), stained for virus antigens in cultures producing the mutant or wild-type virus. In addition, larger amounts of viral proteins were detected in the mutant virus-infected cells (Fig. 2A) .
The structure of viral genomes was analyzed in cells infected with the orf-B mutant viruses by means of Southern blotting. The restriction endonuclease Bgl II produces a 1.07-kilobase (kb) viral DNA fragment encompassing the off-B region in wild-type viral DNA (Fig. 2B, lane 1) .
Digestion of whole cell DNA from cells infected with the mutant virus recovered from p9B-9ZX with Bgl II produced a 0.91-kb DNA fragment, which is anticipated from the size of the deletion in p9B-9ZX (Fig. 2B, lane 2) . In this analysis, we noted that cells infected with all three orf-B mutants contained =5-fold more viral DNA than cells infected with wild-type virus ( Fig. 2B; unpublished Table 2 . Detection of virus in RD-4 cells was enhanced by cocultivation with mitogen-stimulated human PMC.
greater quantities in cells infected with the orf-B mutant p9B-9ZX (Fig. 2B, lane 4) than in cells infected with the wild-type virus (lane 3).
Complementation Tests for Virus Recovery and Cytopathology. To demonstrate that the mutant proviral DNA clones tested in these experiments were competent for transfection, we cotransfected pairs of mutant genomes containing nonoverlapping deletions and monitored virus production. Each of the gag gene mutants, p9B-13ZA and p9B-22ZA, were cotransfected with the env gene mutant p9B-12ZS. Infectious cytopathic virus was recovered from these pairwise transfections (Table 4) . Cotransfections with either of the pol mutants (p9B-27H and p9B-32H) along with any of several other mutants also gave rise to infectious virus. The same result was obtained by cotransfection of the tat mutant (p9B-5XM) with a gag mutant (p9B-13ZA) or with the env mutant (p9B-12ZS). Moreover, cotransfection of the off-A mutant p9B-1N with a nonoverlapping mutant in gag (p9B-13ZA) or env (p9B-12ZS) gave rise to high levels of infectious cytopathic virus. In contrast, cotransfection with both overlapping gag mutants p9B-13ZA and p9B-22ZA did not yield infectious virus.
These complementation experiments established that each mutant DNA form was taken up by cells in the transfection procedure. Also, none of these mutations were lethal in a dominant fashion; the putative aberrant gag, pol, and env gene products of the respective mutants did not prevent formation of infectious virus in these pairwise cotransfections. Further characterization ofthe genomes ofthe progeny viruses from these cotransfections may reveal the presence of pseudotypes, recombinant genomes, or mixtures of both. DISCUSSION Recombinant DNA techniques have been used with the HIVSF2 genome to provide a genetic analysis of selected portions of the AIDS retrovirus. The studies reported here emphasize the value of specific mutations in unique regions of HIV (orf-A, orf-B, and tat), to investigate their roles in virus replication and cytopathology.
Mutations in the known genes of HIV-gag, pol, and envprecluded efficient replication and induction of cytopathology by the virus. This lack of production of infectious HIV following mutations in the major structural genes of the virus was expected; similar observations have been made with other retroviruses (41 (42) . A plasmid containing the tat gene increased chloramphenicol acetyltransferase activity (CAT) in human T cells cotransfected with a plasmid containing the bacterial CAT gene under the control of the long terminal repeat of HIV (19) . The mutant form of the tat gene in p9B-5XM, when tested by this assay, was found to be inactive for transactivation (B. Peterlin, M. Walker, P. Barr, and P.A.L., unpublished results). These results support the idea that the predicted tat gene product is required for viral gene expression and for production of infectious virus.
The data on mutations in unique regions of HIV gave some noteworthy results. The orf-A mutant (p9B-IN) has a 2-bp insertion near the 5' end of the coding region, which would be predicted to prematurely terminate translation of the p23 product. This mutation appears to dramatically affect the efficiency of virus replication, although progeny HIV was detected (Table 2) . Cytopathology was not observed, perhaps because of low levels of virus produced by p9B-1N. Mutations characterized by large deletions in orf-A of the HTLV-III B10 cloned provirus of HIV also gave rise to low levels of virus production, as reflected by a delay in the spread of virus in cultures cocultivated with mutant-transfected cells (43) . However, in contrast to our results, cytopathology was observed in these cultures. A B-lymphocyte line (Raji-tat111) constitutively expressing the tat protein (44) was used as a recipient cell line for transfection in this other study (43) . Thus, the attenuated functions in the orf-A mutants may have been complemented by the tat gene product. Furthermore, the C8166 cell line used in cocultivation of the transfected Raji-tat1i cells was shown to be very sensitive to HIV infection and cytopathology (45) . Thus, the variation in assay systems between our study and that of Sodroski et al. (43) could explain the differences observed.
Deletion mutants in orf-B of HIVSF2 yielded viruses that replicated to higher titers than wild-type virus. Moreover, increased amounts of viral DNA, both proviral and unintegrated forms, were produced in lymphoid cell cultures infected with these deletion mutants. Deletion mutants in the off-B region of the HTLV-III pHXB2D cloned provirus have been reported to give rise to viruses that are highly infectious and extremely cytopathic (46) . Although no quantitation in virus production was presented, this enhanced viral cytopathology may indicate that these mutants also had increased replicating ability. The p27 protein encoded in the orf-B region is immunogenic in infected individuals (15, 16) and is also recognized by sera of monkeys infected with the simian T-cell lymphotropic virus type III (STLV-III) (15) . These findings of a conserved region in these viruses implicate an important functional role for the orf-B protein either in viral replication or in the biological effects exerted by the virus in infected cells. Such a function may be in determining replicating ability of HIV in different cell types. The data obtained with these orf-B mutants suggest that the p27 protein functions to down-regulate virus production in infected cells. This observation points to another level of regulation of HIV gene activity and provides a potential target for controlling HIV replication.
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